AMCR Institute Competitors and Similar CompaniesClear all

Vascular Pharmaceuticals's competitors and similar companies include Profil, CenExel ACT and Larimar Therapeutics.
Vascular Pharmaceuticals
Vascular Pharmaceuticals
Vascular Pharmaceuticals is a biopharmaceutical company specializing in the complications of diabetes, specifically diabetic nephropathy.
Profil
Profil
Profil Institut für Stoffwechselforschung is a clinical research organisation for studies related to diabetes and obesity.
CenExel ACT
CenExel ACT
CenExel ACT (also known as Anaheim Clinical Trials) is a medical research center administrating phase 1 – 4 clinical trials.
Larimar Therapeutics
Larimar Therapeutics
Larimar Therapeutics (formerly known as Zafgen) is a biopharmaceutical company dedicated to improving the health and well-being of patients affected by obesity and complex metabolic disorders.
Founding Date
Founding Date
2005
Founding Date
1999
Founding Date
2009
Founding Date
2005
Type
Type
Private
Type
Private
Type
Subsidiary
Type
Public
Tags
Locations
Locations
US HQ
Chapel Hill, US
Locations
Neuss, DE HQ
Mainz, DE
Locations
Anaheim, US HQ
Anaheim, US
Locations
Bala Cynwyd, US HQ
Employees
Employees
6
Employees
200
Employees
6
Employees
782% decrease

Funding

Total funding raised
Total funding raised
$ 28m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 132.2m
For sources of this data, please see the company profile

View Company Profiles

Profil
HQ
Neuss, DE
Employees
200

Profil Institut für Stoffwechselforschung is a clinical research organisation for studies related to diabetes and obesity.

View company
CenExel ACT
HQ
Anaheim, US

CenExel ACT (also known as Anaheim Clinical Trials) is a medical research center administrating phase 1 – 4 clinical trials.

View company
Larimar Therapeutics
HQ
Bala Cynwyd, US
Employees
7

Larimar Therapeutics (formerly known as Zafgen) is a biopharmaceutical company dedicated to improving the health and well-being of patients affected by obesity and complex metabolic disorders.

View company